Toward minimal residual disease-directed therapy in melanoma F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ... Cell 174 (4), 843-855. e19, 2018 | 599 | 2018 |
PintlincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2 O Marín-Béjar, FP Marchese, A Athie, Y Sánchez, J González, V Segura, ... Genome biology 14, 1-17, 2013 | 275 | 2013 |
Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature Y Sánchez, V Segura, O Marín-Béjar, A Athie, FP Marchese, J González, ... Nature communications 5 (1), 5812, 2014 | 211 | 2014 |
The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element O Marín-Béjar, AM Mas, J González, D Martinez, A Athie, X Morales, ... Genome biology 18, 1-15, 2017 | 191 | 2017 |
A cellular hierarchy in melanoma uncouples growth and metastasis P Karras, I Bordeu, J Pozniak, A Nowosad, C Pazzi, N Van Raemdonck, ... Nature 610 (7930), 190-198, 2022 | 107 | 2022 |
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma O Marin-Bejar, A Rogiers, M Dewaele, J Femel, P Karras, J Pozniak, ... Cancer Cell 39 (8), 1135-1149. e8, 2021 | 96 | 2021 |
A long noncoding RNA regulates sister chromatid cohesion FP Marchese, E Grossi, O Marín-Béjar, SK Bharti, I Raimondi, J González, ... Molecular cell 63 (3), 397-407, 2016 | 92 | 2016 |
Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia I Vázquez, M Maicas, J Cervera, X Agirre, O Marin-Béjar, N Marcotegui, ... haematologica 96 (10), 1448, 2011 | 64 | 2011 |
RNA pulldown protocol for in vitro detection and identification of RNA-associated proteins O Marín-Béjar, M Huarte Regulatory Non-Coding RNAs: Methods and Protocols, 87-95, 2015 | 63 | 2015 |
A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling P Altea-Manzano, G Doglioni, Y Liu, AM Cuadros, E Nolan, ... Nature cancer 4 (3), 344-364, 2023 | 49 | 2023 |
Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion A Athie, FP Marchese, J González, T Lozano, I Raimondi, PK Juvvuna, ... Journal of Cell Biology 219 (9), 2020 | 42 | 2020 |
Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming A Janiszewski, I Talon, J Chappell, S Collombet, J Song, N De Geest, ... Genome research 29 (10), 1659-1672, 2019 | 40 | 2019 |
The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma G Aldave, M Gonzalez-Huarriz, A Rubio, JP Romero, D Ravi, B Miñana, ... Neuro-oncology 20 (7), 930-941, 2018 | 24 | 2018 |
Long noncoding RNAs: from identification to functions and mechanisms O Marín-Béjar, M Huarte Advances in Genomics and Genetics, 257-274, 2015 | 24 | 2015 |
CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance A Gautron, L Bachelot, M Aubry, D Leclerc, AM Quéméner, S Corre, ... EMBO molecular medicine 13 (5), e13466, 2021 | 21 | 2021 |
GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects L Kotmayer, D Romero‐Moya, O Marin‐Bejar, E Kozyra, A Català, A Bigas, ... British Journal of Haematology 199 (4), 482-495, 2022 | 15 | 2022 |
Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma S Diazzi, A Baeri, J Fassy, M Lecacheur, O Marin‐Bejar, CA Girard, ... EMBO Molecular Medicine 14 (3), e15295, 2022 | 14 | 2022 |
A neural crest stem cell-like state drives nongenetic resistance to targeted therapy in melanoma O Marin-Bejar, A Rogiers, M Dewaele, J Femel, P Karras, J Pozniak, ... bioRxiv, 2020.12. 15.422929, 2020 | 4 | 2020 |
Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency O Marin-Bejar, D Romero-Moya, J Rodriguez-Ubreva, M Distefano, ... Haematologica 108 (9), 2551, 2023 | 2 | 2023 |
Blockade of pro-fibrotic response mediated by the miR-143/-145 cluster prevents targeted therapy-induced phenotypic plasticity and resistance in melanoma S Diazzi, A Baeri, J Fassy, M Lecacheur, O Marin-Bejar, CA Girard, ... bioRxiv, 2021.07. 02.450838, 2021 | 1 | 2021 |